Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Receivables: 2011-2025

Historic Change in Receivables for Abeona Therapeutics (ABEO) over the last 12 years, with Sep 2025 value amounting to -$14,000.

  • Abeona Therapeutics' Change in Receivables rose 48.15% to -$14,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,000, marking a year-over-year increase of 100.37%. This contributed to the annual value of -$792,000 for FY2024, which is 138.80% down from last year.
  • As of Q3 2025, Abeona Therapeutics' Change in Receivables stood at -$14,000, which was down 207.69% from $13,000 recorded in Q2 2025.
  • Over the past 5 years, Abeona Therapeutics' Change in Receivables peaked at $3.4 million during Q2 2023, and registered a low of -$3.0 million during Q1 2022.
  • For the 3-year period, Abeona Therapeutics' Change in Receivables averaged around $110,273, with its median value being -$14,000 (2025).
  • In the last 5 years, Abeona Therapeutics' Change in Receivables soared by 242.50% in 2023 and then plummeted by 436.00% in 2024.
  • Over the past 4 years, Abeona Therapeutics' Change in Receivables (Quarterly) stood at -$1.0 million in 2022, then crashed by 47.90% to $20,000 in 2023, then soared by 95.00% to $39,000 in 2024, then skyrocketed by 48.15% to -$14,000 in 2025.
  • Its Change in Receivables stands at -$14,000 for Q3 2025, versus $13,000 for Q2 2025 and -$35,000 for Q1 2025.